# Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning

**Authors:** Lina Kolloch, Philipp Berning, Jörn C. Albring, Julian Ronnacker, Christian Reicherts, Simon Call, Julia Marx, Matthias Floeth, Eva Esseling, Hans Theodor Eich, Christoph Schliemann, Jan-Henrik Mikesch, Georg Lenz, Matthias Stelljes

PMC · DOI: 10.1038/s41409-025-02702-2 · Bone Marrow Transplantation · 2025-08-22

## Full-text entities

- **Diseases:** MDS (MESH:D009190), AML (MESH:D015470)
- **Chemicals:** treosulfan (MESH:C018404)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12583118/full.md

---
Source: https://tomesphere.com/paper/PMC12583118